CV Sciences, Inc. (CVSI) income statement
CVSIOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$0.01−0.00 (-21.13%)
Close on Oct 19, 2026Market cap $2.53MP/E –Yield –
CV Sciences, Inc. income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- 49.5%
- Operating margin
- -2.5%
- Net margin
- -13.7%
- Return on equity, FY2025
- -58.7%
Financial strength
- Current ratio
- 1.18
- Debt to equity
- 0.00
- Debt to assets
- 0.0%
- Cash to current liabilities
- 7.4%
Valuation
- P/E ratio
- –
- Price to sales
- 0.20
- Price to book
- 1.11
- Dividend yield
- –
See a number that looks wrong?